NYSE:LLY
Eli Lilly & Co. (LLY)
1,143.86
+1.01 (0.09%)
as of Oct 5, 2026, 7:59:59 pm Market Open.
221 watching
Financials 
Technical Analysis 0
PAST TOP PICK
(A Top Pick Mar 14/22, Up 34%) Great company with high demand product (insulin).
Building R&D portfolio that is on cutting edge.
New drugs in the pipeline that will be approved.
Weight loss products look promising.
David FingoldOwned
biotechnologypharmaceutical
TOP PICK
Super-excited about long-term prospects from new products, which could lead to 40% sales growth by 2025-26. These products will also increase margins. Biggest opportunity is within weight loss, initial results of a 3-year study are looking good, targeting obesity as well as its complications. Not cheap, but will continue to outperform. Yield is 1.05%. (Analysts’ price target is $381.39)
biotechnologypharmaceutical
BUY ON WEAKNESS
Allan Tong’s Discover Picks You could then take that money and put it in Eli Lilly. There’s potential in LLY stock’s own Alzheimer’s drug. Also, the street is putting its hopes into LLY’s weight-loss drug, Mounjaro, when it starts selling in two or three years. After all, diabetes as at an all-time high in America. One analyst envisioned $25 billion in peak sales, outstripping AbbVie‘s Humira which has topped $20.7 billion. However, the street is getting a little ahead of itself, since the FDA has approved Mounjaro for glycemic control in T2D patients, and LLY still needs to submit the drug as a treatment for weight-loss. Read Mixed bag of 3 Defensive Stocks for our full analysis.
biotechnologypharmaceutical
BUY
Focusing on its diabetes and weight loss drug. The weight loss drug could be one of the biggest drugs of all time, when it starts selling in the next 2-3 years.
Jamie Murray Owned
biotechnologypharmaceutical
BUY
LLY vs. NVO NVO is focused on weight loss and diabetes. One issue is the liquidity, as it doesn't work well for his covered call strategy. Still fairly expensive. LLY had great weight reduction results recently. LLY is at a discounted valuation, a more diversified business, and exposure to Alzheimer's. He prefers LLY, but you'd be OK on both.
Paul MacDonaldOwned
biotechnologypharmaceutical
TOP PICK
Diabetes is an epidemic and LLY is a leader in therapeutics for this disease. Also it is making a major impact in the diagnostics and monitoring of Alzheimer's. Healthcare in general is one of the three best performing industries of all time but has under-performed until the beginning of this year. It has spun off its animal health division. It is defensive and timely in a bear market. Buy 16, Hold 8, Sell 1.
David FingoldOwned
biotechnologypharmaceutical
TOP PICK
There is an epidemic in Diabetes and it is in this field. Also in area of Alzheimers. Has made advancements in diagnostic tools and monitoring and treating patients. This is a defensive business not affected by a slowing economy. Buy 16 Hold 8 Sell 1
David FingoldOwned
biotechnologypharmaceutical
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20scale(-1,%201)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
'%20fill='%23ffffff'%3e%3cg%20id='Pager'%20transform='translate(423.000000,%201755.000000)'%3e%3cpath%20d='M243.295367,17.286474%20C243.68919,16.9045087%20244.327703,16.9045087%20244.721525,17.286474%20L249,21.4361302%20L253.278475,17.286474%20C253.672297,16.9045087%20254.31081,16.9045087%20254.704633,17.286474%20C255.098456,17.6684393%20255.098456,18.2877274%20254.704633,18.6696927%20L249.35654,23.856763%20C249.159628,24.0477457%20248.840372,24.0477457%20248.64346,23.856763%20L243.295367,18.6696927%20C242.901544,18.2877274%20242.901544,17.6684393%20243.295367,17.286474%20Z'%20id='Path'%20transform='translate(249.000000,%2020.500000)%20rotate(-90.000000)%20translate(-249.000000,%20-20.500000)%20'%3e%3c/path%3e%3c/g%3e%3c/g%3e%3c/g%3e%3c/svg%3e)
